India to ban antibiotic pollution from pharma factories

  08 February 2020

The Indian government is to limit the amount of antibiotic residue permitted in wastewater released by drug factories, after a series of stories by the Bureau of Investigative Journalism.

A draft bill published on 23 January introduces limits on the concentrations of antibiotics found in the waste discharged by pharmaceutical factories into rivers and the surrounding environment. Experts believe anything above these limits fuels the creation of drug-resistant bacteria, or superbugs.

The growth in superbugs is one of the biggest public health crises facing the world today. Nearly 60,000 newborns a year die from superbug infections in India. If resistance keeps rising people could once again die from common infections, while procedures such as Caesareans, hip replacements and chemotherapy could become impossible to carry out.

 

Author(s): Madlen Davies
Clean Environment  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!